High Doses Of Vitamin E
Boost Survival Rate 40%; Brain Function And ‘High Wire’ Neuromuscular
Performance Gains Also Significant
Two-years of tightrope and ‘T-maze’ testing
BETHESDA, Md. (Sept. 4, 2005) – Studying how much
longer and “better” mice will live on high doses of vitamin E involves much
time and work – two years of feeding, testing and studying. But based on
earlier results, a joint team from the University of Cadiz, Spain, and the
University of Buenos Aires, Argentina, figured the payoff would be worth the
effort.
Their just-published paper shows that using vitamin E
supplementation physiologically comparable to recent human experiments in
Alzheimer’s Disease patients, resulted in these major findings:
-
male mice showed a 40% increase in median lifespan (to 85 ±
4 weeks from 61 ± 4).
-
17% increase in maximal lifespan (to 136 weeks from 116
weeks).
-
increases in the ability to perform tests measuring
neuromuscular performance (high-wire tightrope) and cognitive exploratory
activity (T-maze); the increases on both tests ranged 9%-24% at 52 weeks,
and 28%-45% at 78 weeks of age.
-
brain alpha-tocopherol content increased 2.5-fold in male
mice taking vitamin E.
-
vitamin E supplementation offset various measures of
mitochondrial function loss in a range of 37%-66% at the 52- and 78-week
test points.
-
all results were significant to a greater than 99%
confidence level.
The paper “Vitamin E at high doses improves survival,
neurological performance and brain mitochondrial function in aging male
mice” appears online in the American Journal of Physiology-Regulatory,
Integrative and Comparative Physiology, published by the American
Physiological Society. Research was by Ana Navarro, Carmen Gomez,
Maria-Jesus Sanchez-Pino, Hipolito Gonzalez and Manuel J. Bandez of the
University of Cadiz, Spain, and Alejandro D. Boveris and Alberto Boveris
of the University of Buenos Aires.
Results seen supporting ‘free radical’ theory of
aging
Alberto Boveris, professor at the University of Buenos
Aires, said the results of these extended experiments “are in line with the
free radical theory of aging put forward by Gerschman and Harman in the
1950s. Our results show a significant negative correlation between the
mitochondrial content of the oxidation products of free-radical mediated
reactions and mitochondrial enzymatic activities.
“Moreover, brain mitochondrial enzymatic activities
were linearly related to mice success in the tests of neuromuscular function
and of exploratory and cognitive activity and to the maximal mice life
span,” Boveris reported. He noted that the amount of vitamin E
supplementation was metabolically and physiologically similar to the
1200-2000mg. daily dosage for two to three years used in two Alzheimer’s
Disease experiments involving over 400 patients without adverse effects.
The paper observes that the “study shows the beneficial
effects of high doses of vitamin E on the median and maximal lifespan of
male mice, an effect that is parallel to a beneficial effect on the decline
of neurological performance and mitochondrial function associated with
aging.” It said the “marked increase” in median lifespan and the moderate
rise of maximal lifespan “is properly described as a delay in the onset of
the almost linear decay in mice survival.”
The mice used in the experiment, the CD-1/UCadiz, are a
senescence accelerated strain with a median lifespan of 60-70 weeks and
maximal lifespan of 100-120 weeks. Vitamin E supplementation of the test
group began at age 28 weeks.
Role of vitamin E as antioxidant; support for
‘specificity’ concept
The researchers noted that the “mitochondrial content
of lipid protein oxidation products, an indication of free-radical mediated
reactions and oxidative damage, was increased in the brain and liver of
aging mice, and the effect was partially [and significantly] prevented by
vitamin E. The protein carbonyl content of brain mitochondria, taking
28-week-old mice as reference, increased 33%-69% at 52 and 76 weeks, and
this increase was markedly prevented (76% and 65%) by vitamin E
supplementation” measured at the two age points.
Vitamin E supplementation was “able to prevent the
decrease in the activities of brain enzymes that are mitochondrial markers
of aging: mtNOS (by 95%), Mn-SOD (by 60%), and NADH-cytochrome c reductase
and cytochrome oxidase activity” by 35%, the paper said
“The activities of the inner membrane bound mtNOS and
of the matrix enzyme MnSOD in brain and liver mitochondria also decreased
upon aging, in agreement with earlier reports and with the concept of
specificity rather than randomness in the inactivation of mitrondrial
enzymes,” according to the paper. “The activity of mtNOS was decreased by
44%-66% and Mn-SOD by 28%-50% at 52-78 weeks of mice age, effects that were
markedly prevented by vitamin E supplementation,” it added.
Clues to mitochondrial dysfunction -- and next steps
Finally, the authors noted two “interesting
correlations”: The first is the inverse relationship between oxidative
damage and enzymatic activities in the brain and liver, “which are due to
oxidized and damaged proteins, and not to a direct inhibitory effect of
lipid oxidation products (ie., malonaldehyde) due to the high dilution of
the enzymes in the assays” where the reduced rates occurred. The second
correlation shows “that decreased electron transfer rates and limited
respiration and energy supply are the basis of the mitochondrial dysfunction
in aging and that mitochondrial dysfunction is the pacemaker of the decline
in neurological performances which has a determinant role in survival.”
-
Further studies are needed to find the threshold for vitamin
E “doses that provide beneficial effects in the neurological function in
aging mammals,” the study noted.
-
Boveris said the team has completed studies on the role of
calorie reduction (CR), “which could yield interesting results especially
in comparison with similar, but much longer, rhesus monkey studies being
carried out by Richard Weindruch at the University of Wisconsin-Madison on
CR and oxidative stress.”
Source and funding
The paper “Vitamin E at high doses improves survival,
neurological performance and brain mitochondrial function in aging male
mice” appears in the online edition of the American Journal of
Physiology- Regulatory, Integrative and Comparative Physiology,
published by the American Physiological Society. Research was by Ana
Navarro, Carmen Gomez, Maria-Jesus Sanchez-Pino, Hipolito Gonzalez and
Manuel J. Bandez of the Department of Biochemistry and Molecular Biology,
School of Medicine, University of Cadiz, Spain; and Alejandro D. Boveris and
Alberto Boveris of the Laboratory of Free Radical Biology, School of
Pharmacy and Biochemistry, University of Buenos Aires, Argentina.
Research was supported by grants from Ministerio
de Sanidad y Consumo de España, and by Plan Andaluz de Investigación.
Editor’s note: The media may obtain a copy of
Navarro et al. by contacting Donna Krupa, American Physiological Society,
(301) 634-7209, cell (703) 967-2751 or
dkrupa@the-aps.org.
* * *
The
American Physiological Society was founded in 1887 to foster basic and
applied bioscience. The Bethesda, Maryland-based society has more than
10,000 members and publishes 14 peer-reviewed journals containing almost
4,000 articles annually.
APS
provides a wide range of research, educational and career support and
programming to further the contributions of physiology to understanding the
mechanisms of diseased and healthy states. In May 2004, APS received
the Presidential Award for Excellence in Science,
Mathematics and Engineering Mentoring (PAESMEM).
# # #